Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines through an extensive global network that spans more than 110 different countries. Celltrion Healthcare provides REMSIMA, the world's first biosimilar monoclonal antibody (mAb) approved by the European Medicines Agency (EMA) for the treatment of autoimmune disease, and innovative biopharmaceutical medications to help increase patient access to advanced therapies around the world. For additional information on our guidelines, please visit: https://bit.ly/3QyOyt7
View Top Employees from Celltrion Healthcare Co.,Ltd.Website | http://www.celltrionhealthcare.com |
Ticker | KOSDAQ:091990 |
Revenue | $6 million |
Employees | 505 (332 on RocketReach) |
Founded | 1999 |
Phone | +82 32-850-6400 |
Technologies |
JavaScript,
HTML,
PHP
+10 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Health Care, Pharmaceuticals, Retail, Pharmaceutical, Biotechnology |
Web Rank | 7 Million |
Keywords | Advanced Therapies, Autoimmune Disease, Global Network Solutions |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Celltrion Healthcare Co.,Ltd. employee's phone or email?
The Celltrion Healthcare Co.,Ltd. annual revenue was $6 million in 2024.
Scottie Kim is the Chief Compliance Officer of Celltrion Healthcare Co.,Ltd..
332 people are employed at Celltrion Healthcare Co.,Ltd..
The NAICS codes for Celltrion Healthcare Co.,Ltd. are [3254, 32541, 325, 32].
The SIC codes for Celltrion Healthcare Co.,Ltd. are [28, 283].